-
Rage receptors, Taxifolin, Immunotherapy, Cilostazol-Taxifolin, and ApoA-1 as therapeutic targets for CAA
This summary of potential therapeutic targets for treating cerebral amyloid angiopathy is drawn primarily from an important review article, “Models of cerebral amyloid angiopathy-related intracerebral hemorrhage,” published by Sebastian, Vargas-George and Kunjan, R. Dave in “Brain Hemorrhages, Volume 3, Issue 4, December 2022, Pages 189-199.Here is a link to the complete article: https://www.sciencedirect.com/journal/brain-hemorrhages. Editors note:…
-
“Pleiotropic neuroprotective effects of taxifolin in cerebral amyloid angiopathy”
This is a summary of a very interesting publication, with the same title as above, by Takayuki Inoue (Kyoto Medical Center), Satoshi Saito, Masashi Tanaka and edited by Lawrence Steinman (Stanford University School of Medicine). It was published April 29, 2019 in the Proceedings of the National Academy of Sciences (PNAS) 116 (20) 10031-10038Here is…